7552882 Canada Overview

  • Status
  • Acquired/​Merged

  • Latest Deal Type
  • M&A

  • Financing Rounds
  • 1

7552882 Canada General Information

Description

Owner of patents for stem cell therapy. The company owned patents for a stem cell regenerative therapy for pets and horses.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Corporate Office
  • Canada
Primary Industry
Biotechnology
Acquirer
Avivagen
Vertical(s)
Life Sciences
Corporate Office
  • Canada

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

7552882 Canada Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA		 Post-Val Status Debt

This information is available in the PitchBook Platform. To explore 7552882 Canada‘s full profile, request access.

Request a free trial

7552882 Canada FAQs

  • Where is 7552882 Canada headquartered?

    7552882 Canada is headquartered in Canada.

  • What industry is 7552882 Canada in?

    7552882 Canada’s primary industry is Biotechnology.

  • Is 7552882 Canada a private or public company?

    7552882 Canada is a Private company.

  • What is the current valuation of 7552882 Canada?

    The current valuation of 7552882 Canada is 00000.

  • What is 7552882 Canada’s current revenue?

    The current revenue for 7552882 Canada is 000000.

  • When was 7552882 Canada acquired?

    7552882 Canada was acquired on 21-Jun-2010.

  • Who acquired 7552882 Canada?

    7552882 Canada was acquired by Avivagen.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »